Consolidated financial statements

Consolidated balance sheet

in CHF thousands	Note	31.12.2024	31.12.2023
Assets
Cash and cash equivalents	10	31 602	107 640
Trade receivables	11	48 280	71 100
Other receivables	12	9 713	19 285
Inventories	13	74 837	102 077
Prepayments and accrued income		5 200	5 847
Total current assets		169 632	305 949
Tangible fixed assets	14	128 814	221 977
Financial assets	15	27 831	66 339
Intangible assets	16	6 333	3 926
Total fixed assets		162 978	292 242
Total assets		332 610	598 191
Equity and liabilities
Financial liabilities	17	10 986	723
Trade payables	18	34 099	71 039
Other payables	19	2 381	7 724
Provisions	20	2 563	8 848
Accrued expenses and deferred income	21	31 390	32 278
Total current liabilities		81 419	120 612
Financial liabilities	17	7 952	-
Other liabilities		-	48
Provisions	20	33 792	41 260
Total non-current liabilities		41 744	41 308
Total liabilities		123 163	161 920
Share capital	22	900	1 200
Capital reserves		‑ 55	‑ 45
Own shares	23	‑ 400	‑ 408
Retained earnings	24	209 002	435 524
Total shareholders’ equity without minorities		209 447	436 271
Minorities		-	-
Total shareholders’ equity		209 447	436 271
Total equity and liabilities		332 610	598 191

The consolidated balance sheet above contains the financial values indicated not only for the remaining Chemistry and Packaging Divisions but also for the spun-off Paper Division up until its spin-off on 25 June 2024. See also Note 34, Spin-off of the Paper Division.

Download Consolidated financial statements as PDF